Nimes University Hospital — Biomedical Watch V2

Essais liés2clinical trials

VilleNîmeslocalisation

PaysFrancelocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05210621

Molécule	Indication / population	Phase	NCT	Titre	Statut
Two-dose M0-M2 vaccination schedule	SEP	Phase 4	NCT07818356	TACTIC — Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial	NOT_YET_RECRUITING
Ocrelizumab	SEP	Phase 3	NCT05210621	CONSONANCE EX — LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB	ACTIVE_NOT_RECRUITING